Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
 
You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
 
    5
ATC Name B/G Ingredients Dosage Form Price
L01EB01 IRESSA B Gefitinib - 250mg 250mg Tablet, fim coated 141,861,723 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 637,848,621 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 637,848,621 L.L
L04AX06 IMNOVID B Pomalidomide - 2mg 2mg Capsule, hard 637,848,621 L.L
L04AX06 IMNOVID B Pomalidomide - 2mg 2mg Capsule, hard 637,848,621 L.L
A07FA51 INFLORAN B Bifidobacterium infantis - 1milliard, Lactobacillus acidophilus - 1milliard Capsule 647,732 L.L
L04AX06 IMNOVID B Pomalidomide - 3mg 3mg Capsule, hard 662,450,757 L.L
L04AX06 IMNOVID B Pomalidomide - 3mg 3mg Capsule, hard 662,450,757 L.L
L04AX06 IMNOVID B Pomalidomide - 4mg 4mg Capsule, hard 662,450,757 L.L
L04AX06 IMNOVID B Pomalidomide - 4mg 4mg Capsule, hard 662,450,757 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 100mg 100mg Injectable suspension, prolonged release 26,631,226 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 75mg 75mg Injectable suspension, prolonged release 22,121,763 L.L
L01EA05 ICLUSIG B Ponatinib - 15mg 15mg Tablet, film coated 4,487,636 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 50mg 50mg Injectable suspension, prolonged release 16,769,688 L.L
L01EA05 ICLUSIG B Ponatinib - 15mg 15mg Tablet, film coated 4,487,636 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 150mg 150mg Injectable suspension, prolonged release 38,619,396 L.L
L01EA05 ICLUSIG B Ponatinib - 45mg 45mg Tablet, film coated 7,408,556 L.L
L01EF01 IBRANCE B Palbociclib - 75mg 75mg Capsule 246,470,765 L.L
L01EA05 ICLUSIG B Ponatinib - 45mg 45mg Tablet, film coated 7,408,556 L.L
L01EF01 IBRANCE B Palbociclib - 75mg 75mg Tablet, film coated 246,471,257 L.L
L01EB01 IRESSA B Gefitinib - 250mg 250mg Tablet, fim coated 2,326,878 L.L
L01EF01 IBRANCE B Palbociclib - 100mg 100mg Capsule 246,470,765 L.L
L01EF01 IBRANCE B Palbociclib - 100mg 100mg Tablet, film coated 246,471,257 L.L
L01EF01 IBRANCE B Palbociclib - 125mg 125mg Capsule 246,470,765 L.L
L01EF01 IBRANCE B Palbociclib - 125mg 125mg Tablet, film coated 246,471,257 L.L
J07BB01 INFLUVAC TETRA B Influenza virus surface antigens inactivated (haemagglutinin and neuraminidase) - 15mcg/4strains/0.5ml Injectable suspension 970,254 L.L
J07BB02 INFLUVAC B Grippal virus surface antigen 3strains - 15mcgx3strains/0.5ml Injectable suspension 573,821 L.L
N05AX13 INVEGA B Paliperidone - 9mg 9mg Tablet, extended release 5,825,557 L.L
S01BA15 ILUVIEN B Fluocinolone acetonide - 0.19mg 0.19mg Implant 629,182,630 L.L
N05AX13 INVEGA B Paliperidone - 3mg 3mg Tablet, extended release 5,386,121 L.L
    5
Sitemap
© Copyrights reserved to Ministry of Public Health 2024